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1. Introduction
  Typhoid fever, caused by Salmonella enterica serotype 
Typhi (S. typhi), is an infectious disease of global 
distribution, and it remains an important worldwide cause 
of morbidity and mortality[1]. The emergence of multidrug-
resistant (MDR) S. typhi showing resistance to ampicillin 
(A), chloramphenicol (C), trimethoprim-sulfamethoxazole 
(Tm-Smz) and fluoroquinolones, created therapeutic 
problem, and in turn the outbreaks of typhoid fever[2,3]. 
In this situation, the expanded-spectrum cephalosporins 
(parenteral as well as oral) were found effective, plus 
azithromycin could become the preferred drug of choice[4,5]. 
But these agents are expensive for routine use in developing 
countries including India[6]. Moreover, resistance to the 
cephalosporins like ceftriaxone has been reported[7]. This 
situation necessitated the introduction of new treatment 
regimen, and traditional medical practice has been known 
in many parts of the world[8-10]; about 80% of the world 
population depends on traditional medicine for its primary 
health care needs. Tulsi [Ocimum sanctum (O. sanctum) 
Linn., Lamiaceae], the holy basil, is described as medicinal 
plant in ancient literature, and in Ayurveda the plant has 
been well documented for its therapeutic potentials. The 
O. sanctum essential oil has been known to administer 
against asthma, bronchitis, sinus infections, constipation, 
nausea, vomiting and cramp[11].
  The antibacterial activity of O. sanctum is also known. The 
aqueous extract of O. sanctum showed growth inhibitory 
effect on Klesbiella, Proteus, Escherichia coli (E. coli), and 
Staphylococcus aureus (S. aureus); while its alcoholic extract 
had similar effect on Vibrio cholerae (V. cholerae)[12]. The 
O. sanctum alcoholic extract was found to be active against 
MDR S. aureus showing resistance to common 毬-lactam 
antibiotics[13]. Rahman et al[14] reported antibacterial 
activity of O. sanctum leaf methanol extract against gram 
positive and gram negative bacterial pathogens, but they 
did not document the zone diameter of inhibition (ZDI) of 
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the extract for S. typhi. We reported earlier the antibacterial 
activity of different plant extracts excluding O. sanctum 
against various pathogenic bacteria including S. typhi[9,10].
  The synergistic antibacterial activity of plant extract in 
combination with antibiotics has been reported earlier. In 
vitro synergistic interaction of crude extracts from Camellia 
sinensis, Lawsonia inermis, Punica granatum, Terminalia 
chebula and Terminalia belerica was detected with 
tetracycline (T) against S. aureus; moreover, the C. sinensis 
extract showed synergism with A[13]. We for the first time 
reported synergistic anti-S. aureus activity of amoxicillin in 
combination with Emblica officinalis and Nimphae odorata 
extracts[10]. No report has been documented, at least from 
our part of the globe, the antibacterial actvity of O. sanctum, 
against S. typhi, alone or in combination with antibiotic. 
Herein, an in vitro study has been designed to ascertain 
the potential antibacterial activity of O. sanctum, and the 
possible synergistic action in combination with C and Tm 
against the clinical S. typhi isolates.
2. Materials and methods
2.1. Bacterial strains
  The MDR S. typhi (n=23), isolated from blood samples from 
enteric fever patients, who attended the Calcutta School of 
Tropical Medicine, India for treatment, were used in the 
present study; the S. typhi isolates were associated with the 
enteric fever outbreaks in and around Kolkata, India[15]. The 
control strain used was E. coli ATCC 25922. 
2.2. Plant materials and extract preparation
  The fresh leaves of tulsi (O. sanctum) were collected from 
Kallabera, a village of the district Purulia of the West 
Bengal state, India, and the extracts were prepared following 
the protocol mentioned earlier[10] using 50 g of the dried 
materials, and ethanol as the extractant. The tulsi leaf 
extract (TLE) obtained was stored at 4 曟 in 50% ethanol 
(final concentration of 10 mg/mL), and was utilized within 
one week; the extracts were prepared freshly when needed.  
2.3. Agar diffusion susceptibility
  The antibacterial activity of TLE was assessed for 23 S. typhi
isolates following agar diffusion technique. The test protocol 
has been described in our earlier publication[10]; briefly, 
the extract (500 毺g, i.e., 50 毺L), alone was dropped on 
one of the two properly marked sectors, TLE, on Mueller-
Hinton agar (MHA) plates, each of which was inoculated with
10
8 CFU. The second sector, on each of the plates, on which 
dropped 50 毺L of 50% ethanol results no ZDI to ZDI of 6 mm
for the test bacterial isolates, was used as the control. The 
sensitivity to the plant extract for the S. typhi strains were 
considered with ZDI≥7 mm, which has also been considered 
by earlier authors[10].
2.4. Disk diffusion susceptibility
  The susceptibility to C and Tm for the isolates was 
determined by disk diffusion method, using 30 毺g C and 
5 毺g Tm disks (Hi-Media, Mumbai, India). To determine 
the combined effect of C and Tm with TLE, 250 毺g TLE 
(25 毺L) was added to 30 毺g C and 5 毺g Tm disks placed 
on the surface of MHA plate inoculated with 108 CFU. The 
antibacterial activity of TLE alone was also recorded using 
250 毺g (25 毺L) of the extract. 
2.5. Interpretation of the results
  The antibacterial activity of the agents was expressed by 
measuring the ZDI due to the action of the plant extract, 
alone or in combination with C and Tm, and C and Tm 
alone, after 24 h incubation at 35 曟. The effect between 
the two antimicrobial agents was considered synergistic 
by the increase of ZDI from combined action compared to 
the average ZDI obtained due to single action of the two 
components; when zone diameter was less in combination, 
the interaction is defined as antagonistic, and additive when 
there was no change in ZDI in combination[10].
  The growth inhibitory indices (GIIs) were calculated 
following the formula: [ZDI in combination / (total of ZDIs of 
the two agents in single action)][10], in order to corroborate 
the synergistic activity (as has been defined in terms of 
increment of ZDI) of the antibiotics in combination with the 
plant extract. The synergistic, additive and antagonistic 
activities, if any, in between the two of the antimicrobial 
agents were defined with GIIs > 0.5, 0.5 and < 0.5, 
respectively[10]. 
2.6. Statistical analysis
  The 氈
2 test was employed in order to compare the 
antibacterial activity (in terms of ZDIs) of the antibiotics (C 
and Tm) alone and that of the antibiotic (C or Tm) plus TLE, 
against S. typhi isolates; a P value of ≤0.001 was considered 
significant. 
3. Results 
  The antibacterial activity of TLE (500 毺g), in terms of ZDI, 
for S. typhi isolates is depicted in Figure 1. The ZDIs for 
the isolates ranged 16-24 mm; most of the isolates (n=15; 
65.22%) had ZDIs 17-21 mm.
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Figure 1. Zone diameter of inhibition (ZDI) of O. sanctum leaf 
ethanolic extract (TLE; 500 毺g) for S. typhi isolates (n=23).
 
  Figure 2 shows the ZDIs, for the test isolates, of TLE (250 
毺g) and antibiotics alone, and TLE plus the antibiotic (C 
or Tm). The isolates were resistant to both the antibiotics, 
C and Tm (ZDI 6 mm), while ZDIs from the action of TLE 
ranged 11-13 mm; thus, the active most agent of the current 
study was TLE. The ZDIs due to the action of C plus TLE and 
Tm plus TLE ranged 15-21 mm and 17-23 mm, respectively. 
The GIIs for the S. typhi isolates are represented in 
Figure 3. The GIIs values were > 0.5, and ranged 0.789-
1.235 for C-TLE combination and 0.894-1.352 for Tm-TLE 
combination. 
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Figure 2. Zone diameter of inhibition (ZDI) of O. sanctum leaf 
ethanolic extract (TLE; 250 毺g) alone and in combination with 
chloramphenicol (C) and trimethoprim (Tm) for S. typhi isolates 
(n=23).
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Figure 3. Growth inhibitory indices from combined action of 
O. sanctum leaf ethanolic extract (TLE) and antibiotics for S. typhi 
isolates (n=23). C = chloramphenicol, T = trimethoprim.
4. Discussion
  Tulsi (O. sanctum) is abundantly available, easily 
accessible, economically feasible and culturally acceptable 
medicinal plant that exhibit less side-effect, and hence 
it can be recommended for long-term use. The important 
advantages of medicinal plants in various treatments include 
the safety besides their less expensiveness, efficacy and 
availability; the use of such plants in folk medicine suggests 
that they represent an economic and safe alternative to 
treat infectious diseases[16]. The O. sanctum, which in 
Sanskrit means “the incomparable one”, is grown widely in 
India and is taken as the most sacred plant, and the whole 
plant is used as a source of remedy for a wide spectrum of 
diseases[17]. The use of this herb has been reported in Indian 
traditional system of medicine, and currently its application 
is receiving wide spread attention[18]. In this communication, 
TLE was found excellent against S. typhi associated with the 
enteric fever outbreaks in and around Kolkata, India.
  The O. sanctum antibacterial activity has been reported 
earlier. The aqueous extract of O. sanctum showed wider 
ZDI for Klebisella, E. coil, Proteus and S. aureus while the 
alcoholic extract had ZDI for V. cholerae[11]. Mahmood et 
al[19] recorded higher antibacterial activity of Ocimum 
essential oil in gram positive bacteria compared to gram 
negative bacteria; however, Mishra and Mishra[20] found 
O. sanctum essential oil equally effective against both gram 
positive and gram negative bacteria. The ZDI was 17 mm 
due to the action of methanol extract of O. sanctum leaf 
against S. aureus[14]. The O. sanctum ZDI for S. typhi was 6 
mm, as has been reported by Joshi et al[16]. The O. sanctum 
essential oil exhibited antibacterial activity against other 
enteric pathogens like E. coli, P. aeruginosa and P. vulgaris 
with ZDIs 10.5, 8.23 and 8.9 mm, respectively[21]. The
O. sanctum showed significant antibacterial activity against 
human pathogenic bacteria like E. coli, Klebsiella sp., 
Proteus mirabulus (P. mirabulus), Pseudomonas aeruginosa 
(P. aeruginosa) and S. aureus with maximum ZDI against 
S. aureus (20 and 41.5 mm), and minimum ZDI against 
E. coli (10.2 and 17.8 mm) using 5 and 10 毺L of essential 
oil, respectively[19]. The current study demonstrates a 
concentration dependent activity of TLE against S. typhi;
ZDIs ranged 11-13 mm and 16-24 mm, when TLE 
concentrations were 250 毺g/mL and 500 毺g/mL, 
respectively, and thus the isolates were found sensitive 
to the agent. The hexane extract of leaves of O. sanctum 
(eugenol) had antibacterial activity with a minimum 
inhibitory concentration (MIC) of 85-256 毺g/mL against 
Neisseria gonorrhoeae[22]. The essential oil has been 
reported to show growth inhibitory effects of Mycobacterium 
tuberculosis; it has one tenth anti-tubercular potency of 
streptomycin and one-fourth that of isoniazid[23]. Goel[24] 
reported that O. sanctum leef extract effectively enhanced 
activation in macrophage and lymphocytes, depicted by the 
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elevated serum concentration of TNF-毩, IFN-毸 and IL-2 
cytokines, leading to induce a protective resistance against 
Salmonella typhimurium infection.
  Eugenol (l-hydroxy-2-methoxy-4-allylbenzene), 
the active constituent present in O. sanctum, is mainly 
responsible for the therapeutic potential of the plant[22,25]; 
the other important constituents include carvacrol, and 
ursolic acid[26]. Recent studies showed linalool[27,28], methyl 
eugenol[29] and methyl chavicol[27] as lead compounds in 
the composition of O. sanctum essential oil. Thus, it is 
reasonable to speculate that the antimicrobial activity of
O. sanctum can be attributed to the single or combined 
action of these molecules; the wider ZDI (16-24 mm) of TLE 
against S. typhi in the current communication supported this 
view. The tulsi fixed oil showed good antibacterial activity 
against Bacillus pumilus, P. aeruginosa and S. aureus; 
the higher content of linolenic acid in the fixed oil could 
contribute towards its antibacterial activity[30].
  Synergism between known antimicrobial agents and 
bioactive plant extracts is a novel concept and has currently 
been described against infectious diseases[31]. Interestingly 
enough the combination C/Tm-TLE administered against 
the S. typhi isolates augmented the efficiency of the two 
antibiotics under consideration in the present study. 
Darwish et al[32] demonstrated an improvement of the 
efficacy of gentamycin (G) and C against S. aureus by 
the use of plant materials. Adwan et al[33], using well-
diffusion method, showed additive  interaction between 
water extracts of plants (Psidium guajava, Rosmarinus 
officinalis, Salvia fruticosa, Majorana syriaca, Ocimum 
basilucum, Syzygium aromaticum, Laurus nobilis and Rosa 
damascene) and antimicrobial agents (oxytetracycline; Tx, 
G, penicillin G; PG, Smz and enrofloxacin; Rfx) against
S. aureus, while using microdilution method synergistic 
effects of antibiotic-plant extracts combination was 
achieved with significant reduction in the MICs of the 
antibiotics against the test isolates. Synergy testing between 
plant extracts (Rus coriaria, Sacropoterium spinosum and 
Rosa damascena) and antibiotics (Tx, PG, cephalexin, Smz 
and Rfx) against MDR P. aeruginosa isolates, following 
microdilution method, demonstrated a decrease in the MICs 
of the test antimicrobial agents, which thus be useful in 
fighting emerging drug-resistance[34]. Ahmad and Aqil[35] 
found synergistic interaction between crude extracts of 
Indian medicinal plants and antibiotics (T and ciprofloxacin) 
against extended spectrum 毬-lactamase producing 
multidrug-resistant enteric bacteria. The Tx presented 
synergism with methanolic extract of Thespesia populnea;
S. typhi and Shigella boydii shows higher synergism, 
which has been indicated by large ZDI (32-36 mm)[36]. The 
tea extract showed synergistic activity with C and other 
antibiotics like G, methicillin and nalidixic acid against 
enteric bacteria[37]. The O. gratissimum leaf ethanolic 
extract showed synergistic activity against P. aeruginosa 
P. mirabilis in combination with Cp, against P. mirabilis 
and E. coli in combination with A, and against E. coli in 
combination with septrin[38]. The strong synergy observed 
between the action of TLE and C/Tm in our study is a 
significant finding demonstrating the therapeutic potentials 
of this plant; the increased ZDI of C plus TLE (15-21 mm) 
and Tm plus TLE (17-23 mm), and the GIIs values > 0.5, 
0.789-1.235 for C-TLE combination and 0.894-1.352 for 
Tm-TLE combination supported the fact mentioned above. 
The current findings are consistent with the earlier in vitro 
studies that documented synergistic effects with significant 
increase in the ZDI of the antibiotic due to combined action 
of amoxicillin with crude plant extracts against S. aureus[10]. 
Thus, the evidence of in vitro synergism suggests the 
possibility of concurrent use of cost effective conventional 
anti-typhoid antibiotics (like C and Tm), in combination 
with the plant extracts, in treating human infection due to 
MDR S. typhi, when the agents no longer effective during 
monotherapy. However, future research based on animal 
models, may resolve in vivo efficacy of O. sanctum, either 
alone, or in combination with antibiotics.
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